would you buy some pfizer?the market has had a full 10% correction. it was overbought, it's no longer overbought, 12 or 13 times earnings. >> howard, i've gotten more out of doug holtz-eakin, who is an economist. he told me to get the hell out of facebook. you're the one that's supposed to be doing this thing. doug, should i buy anything? how about pfizer today in. >> i think buy clear high tech stocks in drugs and technology. >> there you go. >> i want you to take advantage of the correction. >> you do? >> yes. >> i want you to buy some stocks that have had a percentage double digits pullback. if you don't own google or qualcomm buy, buy them. big correction in energy, buy eog, schlumberger. >> now we're talking. >> go buy starbucks, buy nike. >> industrial names. >> emerson, eaton, ge. >> you have to pound the table. >> i'm getting excited talking about these names now. take advantage of the direction. don't be a dear in the headlights and make it work to your advantage. that's what i'm going to do maybe agai

trust to be able to exercise oversight over agencies we have congress and in this case we have the pfizer court and neither of those bodies are really able to access all of the information and what we've been pushing for what we asked for only testified before congress was more oversight more reporting to congress to the american public so people can look at what the agencies are doing and can judge for themselves whether or not this is really necessary or effective do you think the this new letter that the senators did and i also just the case that might go to the supreme court do you think that this will eventually close these backdoor loopholes of kind of rampant surveillance or do you think that this will just continue to expand hopefully i have some hope for the supreme court given the case that they decided this last term u.s.b. jones where they told law enforcement that it wasn't able to warrantless li g.p.s. track people so place a g.p.s. tracking device on the car without a warrant they said no that's not all right and it was a unanimous decision and they had some very strong lan

they want to know how many americans are being monitored under the pfizer law the n.s.a. is response none of your business will tell you about this privacy catch twenty two . and some consider deserved punishment others say it's torture now the u.s. senate is holding a hearing but the use of solitary confinement in american prisons for you with a piece of the emotional testimony and ask our guest if prison reform is in america's future. one day june twentieth five pm in washington d.c. . you're watching our t.v. to avoid being extradited to sweden in nine days within weeks founder julian assange is now seeking political asylum in the ecuador embassy in britain as you might remain inside the embassy for two days this is a relatively short amount of time considering some of the other asylum cases we've seen worldwide over the years. here's a look at some top asylum cases from around the world the longest asylum case took place during hungary's communist regime roman catholic cardinal you'll have been senti lived inside the u.s. embassy in budapest from one thousand nine hun

elizabeth herbert, representing the ceo of pfizer. the only time you will be able to write on a city building, without him coming after you. i want to introduce the director of public works. >> good morning. how about a big hand for giving the hospital this far? [applause] we appreciate the partnership that we have with the department of public health. in addition to rebuilding come up we are renovating clinics all over the city. -- rebuilding, we are renovating clinics all over the city. this involves a lot of collaboration and innovative projects. under the management of his team -- joe chin and edgar lopez -- we are building a world-class a hospital for the citizens of san francisco. the hospital will use an estimated 20% less energy, 40% less water than regular buildings around san francisco. it will be a rooftop garden. we have light-reflecting roofing material. this is not only for the patients and there families, but to reduce the like which keeps our city cooler. we will use 30% less water to keep the hospital looking green. w

pfizer. listen, i know, pfizer doesn't excite you anymore, but it's up about 15%, s&p's flat. how about this covidien. the very boring formula company back in 2009. guess what it's triple. the track record for these pharma breakups is fantastic. i think it will be the same for jnj. johnson & johnson has some revolutionary drugs that we don't even care about. if jnj were to break itself up, its standalone drug business would be the best big pharma company out there with the portfolio drugs that treats a wide range of diseases. unlike other big pharma places, the big wave is behind them. jnj has a terrific pipeline to more than offset the losses from going generic. been getting more data on the prostate drugs at the american society of clinical oncology meeting this weekend. it's going to be good. imagine, data comes out, nobody cares because nothing was done in europe over the weekend, jnj opens down a dollar, there's your chance. finally. here's a stock that you can buy every day. i came in shortchanged in the '87 crash. i had a huge number of option. i was worried about the s

rival pfizer recalled pills because of a similar problem. lot numbers are on our web site under see it on tv. >> something you buy almost every time you go to the store about to get more expensionive. >> yes. got milk? >> got milk. there you go. milk prices could soon spike because of the high costs of feed, dairy men and wim women been twiming their heard. now there is concern the milk supply could be hurt. the future is now. >> there are 40 less semi loads of milk go together market than last year start shopping for the best prices. you're going to want to know it. >> george millering can for an investigation into sweetheart deals between universities and banks. there is concern they're being steered into high-cost debit cards. saying nine million students are in danger of being nickeled and dimed to death. culprit, campus debit cards charging fees for every transaction, balance inquiries and foreclosing those accounts. get being around on american airlines is going to be a harder. the airline cutting flights by 1 to 1.5%. the reason? pilo

elizabeth herbert, representing the ceo of pfizer. the only time you will be able to write on a city building, without him coming

. >>> pfizer and bristol-myers squibb both sank after federal regulations delayed approving their highly touted blood-thinning drug. microsoft sealed its $1.2 billion deal to buy yammer, the so-called social network for the workplace. speaking of social networks, check your facebook settings. yesterday without asking users, default e-mails were changed to their facebook.com address. >>> starting today, spirit airlines is charging a dollar to print your boarding pass at the airport. "the wall street journal" reports orbits has been showing mac users different and sometimes pricier travel options after finding apple users spent as much as 30% more on hotels than p.c. customers. >> and, finally, who says gambling doesn't pay? well, sort of. it turns out an anonymous donor who gave $1 million to united way, which was distributed in $500 gift cards to nevada families over the weekend was las vegas casino owner steve wynn. well, some good news there. >>> coming up, the cards win in extras, the yanks tee off, and a pair of upsets at the world's oldest tennis tournament. >>> plus, a washington n

pfizer and bristol-myers squibb both sank after a blood-thinning drug. >>> speaking of social networkscheck your facebook settings, yesterday, without asking users' default emails were changed to their facebook dot-com address. >>> starting today, spirit is charging $1 to print your pass at the airport. >>> orbitz is showing pricier hotel options. >>> and who says gambling doesn't pay? sort of, it turns out an anonymous donor who gave $1 million to united way, distributed in $500 gift cards to needy nevada fans over the weekend, was las vegas casino owner, steve wynn. >>> coming up, the cards win in extras, the yanks tee off and a pair of upsets in wimbledon. >>> plus a washington nationals pitcher lets a fastball get away, along with his win streak. you're watching "first look" on msnbc. our cloud is made of bedrock. concrete. and steel. our cloud is the smartest brains combating the latest security threats. it spans oceans, stretches continents. and is scalable as far as the mind can see. our cloud is the cloud other clouds look up to. welcome to the uppernet. verizon. and this is wh

he did pfizer is maybe issued as we go into the weekend. it says to me and sticking into monday and tthe chance of an afternoon storm. the fourth of july looks ok. i temperatures around 88. >> it turns out there is another competitor who is headed to london. >> was there are so many seats in >> we go now to the countdown to london 2012. we want to tell you about another swimmer with local ties who is qualified for the olympics. she is alison schmidt and she solidified her spot on the team. she is 22 and trained with michael phelps. this will be her second olympic games. last night's race was tough. >> i tried to hold on. they got me through that. >> alisyn was born in michigan but she relocated to our area three years ago. we will clean her. -- claim her. >> the two athletes will be competing in another final for a chance to represent the u.s. we have more on what happened in the pool. >> at the swimming trials, the spotlight was squarely on michael phelps. his rival took the morning off and michael phelps was the third fastest qualifier. t

without providing the government to provide an individualized application that brought the operation of pfizer back in line with the original intent. second it established a system of oversight by the fisa court and congress and various actionors within the executive branch to ensure this would be exercised in compliance with the law and the constitution. third, significantly added to the protections by imposing the requirement for the first time that the government seek and obtain an individualized order from the fisa court when it seeks to conduct intelligence on a u.s. person for that u.s. person who is outside the united states. the fisa amendments act was a well-calibrated piece of legislation. in supporting the administration's call, i asked congress to focus on the three considerations that have been the focus of my remarks here today. the vital importance of the faa authority to our counter terrorism efforts. two, the extreme care with which members considered, craft and limited that contract when they passed the faa and three, the representations that that authority has been implement

pfizer obviously if you think the world is coming to an end, people go to pfizer.hey draw and they always come back to bristol myers. because what does greece have to do with the price to earnings multiple? >> not too much. at least not today. >> no. >> remarkable this call, as you pointed out before. the first time this analyst has recommended j & j in 3 1/2 years. he took it down just as the financial crisis was hitting, was getting to its worst. that's why this call is so watched here on the street at this point. we've actually got the analyst tonight on "fast money" at 5:00. we'll ask him a little bit more behind this call. we're also watching shares of zynga up almost 2% after hitting all-time lows yesterday. data showing daily active users actually decelerated in the latest period. >> past two months. >> today an upgrade. time to step in. a little confusing to me in the ever corp. note. it's trading in line with peers like activision. later it says it's trading at a premium to its years. we need some clarification on that. anyway, it's higher today. >> yelp,

i remember one of the cases, i think it was a pfizer study that looked at this, was a woman w who -- this isn't necessarily a chronic care condition, but a woman who was taking care of her child who had an ear infection. she had a liquid antibiotic which she was putting in the ear instead of the mouth. nobody had showed her. we also know know from the work on hot spots for example in camden that there was a gentleman, many of you know this particular case. i think it's very telling. a person -- a person with diabetes who kept coming back into the e.r., that there was a certain pattern. finally, someone said, well, let me see you give you your insulin. why that wasn't done earlier, but that's the nurse in me. he was putting the syringe into the bottle and pulling up. instead of flipping the bottle. in order n the beginning of the prescription he was probably getting the insulin he needed. but then he was just getting air and injecting air. so it was a big revelation. well, now we know how to manage this person's condition. so this to me is getting into a health work force issue. as we

sacred to every cell of feet shot so as not to draw too much attention he says everybody sekret pfizer's something these days just to see their mission and i sobbed. syria completed. reporting from northern lebanon. all the top level two of you are europe president putin said this last week that he urged patience to let the kofi annan plan come into effect in syria he was speaking ahead of a meeting with european leaders in some petersburg which kicks off later on sunday got a lot to discuss too as you want to explain. was it puts in his first stop was in minsk which many saw as an indication that russia's foreign policy now will focus more on the closest neighbors and the c.i.s. countries many observers also saw this visit as the beginning of the supposed plan of economic and eastern bloc now off you went afterwards to berlin on a whirlwind visit which lasted for only half a day was going to put an end german chancellor angela merkel who seemed to see eye to eye on the matters concerning syria now earlier in the week u.s. secretary of state hillary clinton said that russia is aiding to

he said pfizer a kick in. -- a heat advisory taking in.kype conditions vary across the reason. -- vary across the area. mostly sunny skies. warm temperatures. here is where we stand at the moment around the area. most of the temperatures in the 60's outside of the city. the -- this rise will be steady throughout today. a 74 right now in the district. here is the hourly. this will give you an idea of how quickly the temperatures will rise. it will feel warmer. urey's the heat advisory. -- here is that he devised. your high heat warning in effect for the philadelphia area. relief coming our way? a little bit. highs will go to the upper 80's for the weekend. it will feel over 100 degrees. a little better as we get through the day on friday. citing improvement in the temperatures as we head through saturday and sunday. we will have more for you in 10 minutes. >> looking ahead to the weekend. thank you. >> barely cool down when it is 88. >> we will take it. 95, 66, status quo delays. no surprises on 395. let us see if we can grab a glimpse from

there is an alzheimer's product that they share with pfizer. i wouldn't buy j & j for it.reat entry point in a stock that has not moved. >> is that pipeline reflected or is their upside possibly to the 74 because of the pipeline? >> that probably depends a bit on the tape. if you are looking at a flat market over the next 6 to 12 months you probably need some pipeline to kick in. i think that $74 is a reasonable target and we will see what happened in their end markets and the broader take. >> i am curious on their international exposure and their fx head wind, stuff we have talked a lot about, how does that play into your valuation? >> it's -- it's an issue for all of these companies, right? j & j has large exposures in yump. they hedge out and have a lot of natural hedges. really where they get caught up is in the emerging markets where most companies don't hedge. most of them are relative to the dollar. for j & j, i think it is manageab manageable. those are names we have more concerns on. >> thank you so much for your time. we hope to see you back sometime soon. what d

trevor tim from the electronic frontier foundation is going to fill us in on today's hearing on the pfizer amendments act if congress really going to reauthorize this even though we don't know how many americans communications the government is monitoring and despite the fact that americans get it when fighting in court to find out it seems crazy but it looks like the war on terror just might win out against your privacy then we'll speak with joe weisenthal from the business insider when he gets a predictions for tomorrow's jobs numbers we'll talk about one woman who took on citi group and won in court and the story that joe's been trying to get everyone to pay attention to all week long ten year treasury bond yields at record lows to all of that and more if you tonight including a dose of happy hour but first take a look with the mainstream media decided to miss. well where shall we start today to be honest i wasn't even going to pick on the mainstream media for this one because the story was surprisingly absent from their morning coverage considering how obsessed they've been with it lat

violate our privacy to tell us how despite this ridiculous argument house committee reauthorized pfizer today and the rio plus twenty conference is going on in brazil but thanks distractions like the global economy and a lack of desire to commit it just looks like the stage is set for yet another failed environmental conference we're going to have all of that morphia tonight including a dose of happy hour but first let's take a look what the mainstream media decided to miss. so despite covering some world affairs that are going on the mainstream media is still devoting a considerable amount of time to the presidential race and that's despite the fact that there really isn't all that much to talk about so what do they do well they create a story out of a no on story. so much for romney rubio take has there been some reports this morning that former senator marco rubio who is of course just on everybody's short list from b.p. hasn't been vetted yet by the romney campaign he has not been asked to fill out papers to be vetted as a vice presidential candidate he is not currently being vetted

we like pfizer, and -- >> health insurance companies?ave been ones they with have dipped into because some of their concerns go away. we're still not in the devices, so we would pry hold back, but the drugs and big pharmas are attractive. >> what is the further message with the tremendous volatility we have, disappointment that the fed was not more aggressive with their policy. >> right, they were disappointed. they wanted to welcome further easy, but here we have a big rebalancing going on right now, and the it looks a little biassed. also you have to remember, tuesday for traders end of the month and quarter and half. you could see a pop in energy as president guys get back. we could have a nice week next week. >> what are the expectations for europe? >> no, this is kicking the can down the road. you will probably get short news out there, but in the long run their not creating any jobs. >> i think it's a try yuch of hope over experience. they go into a meeting, summit, weekend, or holiday, whatever it is they say grand things and litt

repeatedly for months now, good dividend payers, health care companies, this is your abbott, johnson, pfizerthree of those things yield above 3% with the treasury yielding below 1.5%. >> peter, you have 97% of the s&p down. we're heading down to the lows. dow is negative for 2012. s&p 500 below the 200-day moving average. how significant is that? >> it is significant but to me this is a buying opportunity. i love the big dips in the market. if you look at u.s. equities, they are probably the best equities to be anywhere in the world. i still think that they are even with a growth rate, you're going to have a better return here than anywhere else it's still a major factor and it's not a risk-free investment but let me tell you something, that mitigates some of the risk when you know you've got answer dividend play out of it. >> you have oil prices dramatically lower than where they were. a performer for a stock that hasn't performed all that well over the last decade. places like that, maybe you should look. where do you like? >> i still love health care stocks. i still think going forward lo

the president has very qualified pfizer's. >> how you separate the government? >> you bring them together. i do not think you ever want to separate things so much that our deliberations are not informed by the experience. you bring the right people with the right expertise. while we may resist, the moving forward we rely on the experts. i think we can advise with the potential is. >> what are you 42? >> 440. >> you look back on your life, can you think of someone that has really spoken well on their feet and impressed to? it does not have to be a politician. why did they press you? >> i think there are a lot of people over time i remember too impressed me. it is not just because i work for them. this present impresses the when he speaks. i want to be inspired when i hear a speech. you have been in this town for decades. you heard a lot of speeches. what i most want when i hear someone talk is someone to inspire. i want to leave that event. i want to leave that event thinking a little bit differently about the problem at hand. the presence inspires me. >> how abo

who knows about general electric, merck, or pfizer if they say we are taking the same pen out of murdoch's. where would that take the dow? here's the bottom line. the bear case sounds so darn smart. i don't want to sound smart. i want to make money. that means considering that there may not be as much bull in the bull case as you think. tom in florida, please. tom. >> caller: jim, the department of education came out easier than expected on the for-profit school regulations and the stock is seeing a nice pop. does this change your mind on the industry? >> no. it's very disputed in terms of the for hires. very disputed in terms of how they are doing. i'm staying bear saying stay away. linda in connecticut. >> caller: hi, jim. go yankees. >> go yankees. >> caller: boo-yah. >> they call me to tell me they need a starting pitcher, so i'm warming upç during the commercl break. >> caller: cool. >> thank you. >> caller: i bought arna today. they improve the health of patients and loved ones like you. what do you think? >> it's come back down. i'm doing the same thing again. i want you to sell ha

we're going to be taking more bills, pharmaceutical stocks and companies like merck, pfizer and eli lillyless regulation, give us the bills -- that tells for teeth. where we go to get our prescriptions filled, this is a very exciting day. >>mark: it's a historic day. you really see the grand bargaining that went on behind getting this law passed. >>rob: the last loser is a medical device companies, they have a 2.5 percent tax on all units sold. airborne to start firing people fear it you will see sales be fired because they have to give of products. it will become much smaller and leaner companies. >>mark: some interesting winners and losers on this historic day. >>jaqueline: here is a live look outside from the golden gate. this afternoon, the fog is clinging to the coastline. widespread fog over night. it has returned. temperatures this afternoon were cooler. he conceded morning fog, closer to the clothesline in the '60s. 69 in oakland this afternoon. a little bit cooler in concord at 82, 85 in pleasanton, 82 is sunnyvale. 70's for the mess -- 70's for the rest of the day's chores. temp

. >> if pfizer has lipitor they don't need walgreens.ecomes a generic drug the distribution system becomes more important. so walgreens does very well every time you have a big drug go off patent. the stock has been hit because of problems with express scripts but that will be resolved here. very cheap on eva to ebitda multi billion. a high class retailer that will do well in the generic wave. >> good to speak with you. >> thanks for having me. >> josh brown being the contrarian. i guess you have a bone to pick with at least one of the picks. >> i hear the word cheap associated with stocks and i cringe. not that i don't want a good value but citigroup, morgan stanley. i will say it for the record. bank stocks without dividends are like bicycles without seats. they are very uncomfortable to ride. >> ooh! >> there is no reason at all to be in citigroup. i don't get it. the microsoft pick is interesting. it's a perennial left behind. i like that one. the bank names, he's got to kick those at some point. not that they can't work. there are e

he points out you buy a 4%, pfizer, at&t, back in the financial break some of these stocks go down 30%ou're not guaranteed just because you have a high dividend you're not going to lose your tuchus. >> dividend stocks are dividend stocks at the end of the day, but they're lower beta. i think they're reasonable places to hide. that said, you can overpay. people were paying a lot of money for safety. there are sectors, particularly in the u.s. like utilities where people are overpriced. there are other places to look, outside of the u.s., asia, even parts of northern europe where you can get that dollar of dividends for a lot less. >> so mike, you see it a little bit differently. you think you might even need some noncorrelated assets in the mix? >> i have a lot of cash right now. i think the market is in for a big sdip. but i diversify. i go with a mutual fund, something like t. rowe price dividend growth fund. they have a big basket in there, the traditional companies. >> farm land? >> i like farm land as well. it's good income producing. you can go to u.s. trust, they'll lease farm la

cells while sparing healthy ones, technology licensed to a number of big pharma players, genentech, pfizermong others. the company isn't yet profitable although it should start making money in 2014 and it does already have one very big drug on the market, a third line treatment for hodgkin's lymphoma and second line treatment for non-hodgkin's lymphoma. they just came out with two positive pieces of data at the oncology conference. we got bullish phase two data about phase two and phase one data a company is working on with castration resistant prostate cancer. let's check in with dr. siegel, the president and ceo of seattle genetics to find out more about these drugs and where this company is headed. sir, welcome to the show. >> thanks. >> all right. now, we had an opportunity here, because so often, clay, what i struggle with, we know that you're targeting non-hodgkin's lymphoma and hodgkin's. you're offering the kind of drug that doesn't bombard or carpet bomb the body but goes right after and i think you got something that's going to show us. >> i do. exactly. we target something calle